Stability of propafenone hydrochloride in i.v. solutions

被引:3
|
作者
Dupuis, LL
Wong, B
Trope, A
机构
[1] UNIV TORONTO,FAC PHARM,TORONTO,ON,CANADA
[2] MERCK SHARP & DOHME LTD,HONG KONG,HONG KONG
[3] HOSP SICK CHILDREN,DEPT PHARM,PEDIAT CRIT CARE UNIT,TORONTO,ON M5G 1X8,CANADA
关键词
cardiac drugs; concentration; containers; dextrose; diluents; freezing; incompatibilities; injections; plastics; polymers; polypropylene; polystyrene; polyvinyl chloride; precipitation; propafenone hydrochloride; sodium chloride; stability; storage; syringes; temperature;
D O I
10.1093/ajhp/54.11.1293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of propafenone hydrochloride in i.v. solutions was studied. Solutions of propafenone hydrochloride 2, 1,and 0.5 mg/mL in 5% dextrose injection and in 5% dextrose and 0.2% sodium chloride injection were prepared. Portions of each type of solution were transferred to 10-mL polypropylene syringes and to 150-mL polyvinyl chloride (PVC) bags. Syringes and bags were stored at 20.5-22.5 degrees C under fluorescent light. Two 0.5-mL samples were drawn from each container at 0, 6, 12, 24, 36, and 48 hours and frozen in polystyrene tubes at -20 degrees C until assayed. Propafenone concentrations were determined by high-performance liquid chromatography. All samples of propafenone hydrochloride 2 mg/mL in 5% dextrose and 0.2% sodium chloride injection taken from PVC bags Precipitated when thawed. For the remaining solutions, the mean decrease from the initial concentration was <10% regardless of diluent, container type, and initial concentration. Propafenone hydrochloride 1 and 0.5 mg/mL in 5% dextrose injection or in 5% dextrose and 0.2% sodium chloride injection was stable for 48 hours at 20.5-22.5 degrees C when stored in polypropylene syringes or PVC bags. Propafenone hydrochloride 2 mg/mL in 5% dextrose injection was stable for 48 hours when stored in syringes or bags, but in 5% dextrose and 0.2% sodium chloride injection was stable in syringes only.
引用
收藏
页码:1293 / 1295
页数:3
相关论文
共 50 条
  • [1] Stability of midazolam hydrochloride in syringes and i.v. fluids
    Pramar, YV
    Loucas, VA
    ElRachidi, A
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (08) : 913 - 915
  • [2] Stability of isoniazid injection in i.v. solutions
    Lee, Jun H.
    Moriyama, Brad
    Henning, Stacey A.
    Danner, Robert L.
    Walsh, Thomas J.
    Penzak, Scott R.
    Grimes, George J.
    Potti, Gopal K.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (10) : 622 - 626
  • [3] Stability of tirofiban hydrochloride in three commonly used i.v. solutions and polyvinyl chloride administration sets
    Bergquist, PA
    Zimmerman, J
    Kenney, RR
    Han, RYH
    Hunke, WA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (16) : 1627 - 1629
  • [4] METRONIDAZOLE HYDROCHLORIDE (FLAGYL I.V.)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1981, 23 (04): : 13 - 14
  • [5] Stability and compatibility of reconstituted ertapenem with commonly used i.v. infusion and coinfusion solutions
    McQuade, MS
    Van Nostrand, V
    Schariter, J
    Kanike, JD
    Forsyth, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (01) : 38 - 45
  • [6] 'I.V.'
    STEWART, J
    SOUTHERN HUMANITIES REVIEW, 1993, 27 (02): : 120 - 120
  • [7] Stability of monoHER in an aqueous formulation for i.v. administration
    Abou El Hassan, MAI
    Touw, DJ
    Wilhelm, AJ
    Bast, A
    van der Vijgh, WJF
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 211 (1-2) : 51 - 56
  • [8] Stability of milrinone lactate in the presence of 29 critical care drugs and 4 i.v. solutions
    Akkerman, SR
    Zhang, HZ
    Mullins, RE
    Yaughn, K
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (01) : 63 - 68
  • [9] INFLUENCE OF THE STRUCTURE OF NEW ANTHRACYCLINE ANTIBIOTICS IN THEIR STABILITY IN COMMONLY USED I.V. INFUSION SOLUTIONS
    Cielecka-Piontek, Judyta
    Jelinska, Anna
    Dolhan, Agnieszka
    Oszczapowicz, Irena
    Wasowska, Malgorzata
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3242 - 3242
  • [10] Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection
    Kintzel, Polly E.
    Zhao, Ting
    Wen, Bo
    Sun, Duxin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (23) : 2061 - 2065